Claire Immediato Daien

8PUBLICATIONS
12CO-AUTHORS
Medical biochemistry - lipidsDisease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 09, 2025
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid Arthritis.

Jürgen Wollenhaupt, Jacques Morel, Claire Daien

|Oct 02, 2024
Systematic screening for multimorbidities in patients with inflammatory rheumatic diseases enhanced preventive medication use and reduced hospitalisations: an exposed-non-exposed study.

Claire Immediato Daien, Vera Georgescu, Guillaume Decarriere

|Jan 31, 2024
Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease.

Claire Rempenault, Cédric Lukas, Léa Tardivon

|Aug 10, 2022
Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control.

Rachel Audo, Pauline Sanchez, Benjamin Rivière

|Aug 10, 2022
Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control.

Rachel Audo, Pauline Sanchez, Benjamin Rivière

|May 31, 2022
Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-TNFα therapy: a placebo-controlled phase II study.

Claire Daien, Marek Krogulec, Paul Gineste

Pageof 2

Frequent Collaborators

3 joint publications

Jacques Morel

1 joint publications

Julie Mielle

1 joint publications

Rachel Audo

1 joint publications

Adeline Ruyssen-Witrand